Vimarsana
Biggest News Aggregation in the World

Page 27 - Analysts 39 Comments News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Analysts 39 Comments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Analysts 39 Comments Today - Breaking & Trending Today

Etsy Is a Favorite Among Gen Z. One Analyst Says This Makes the Stock a Buy. - Vimarsana News

Etsy Is a Favorite Among Gen Z. One Analyst Says This Makes the Stock a Buy.

Piper Sandler analyst Edward Yruma upgraded shares of Etsy to Overweight from Neutral, increasing his price target to $140.

Bed Bath & Beyond Is a Penny Stock. Why Wall Street Still Covers It. - Vimarsana News

Bed Bath & Beyond Is a Penny Stock. Why Wall Street Still Covers It.

Jefferies analyst Jonathan Matuszewski cut his target on Bed Bath stock to 50 cents from $3 on Tuesday. He's one of only eight analysts left who cover the embattled retailer.

Sarepta Has $30 to $40 Upside if Panel on Gene Therapy Drug Positive, Says Analyst - Vimarsana News

Sarepta Has $30 to $40 Upside if Panel on Gene Therapy Drug Positive, Says Analyst

Citi analyst Neena Bitritto-Garg initiates coverage on shares of Sarepta with a Buy rating.

ServiceNow Stock Rallies as Analyst Sees Resilience Despite Macro Weakness - Vimarsana News

ServiceNow Stock Rallies as Analyst Sees Resilience Despite Macro Weakness

The stock should benefit from a combination of “end-market resiliency,” durable growth trends, and a reasonable valuation, according to Baird.

Wall Street Is Bullish on WWE's Stock in UFC Deal. Why This Analyst Disagrees. - Vimarsana News

Wall Street Is Bullish on WWE's Stock in UFC Deal. Why This Analyst Disagrees.

Benchmark analyst Mike Hickey on Tuesday downgraded WWE to Hold from Buy while several others kept their Buy ratings.